Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bio-Rad Laboratories, Inc. Class A Common Stock
(NY:
BIO
)
376.14
-1.55 (-0.41%)
Streaming Delayed Price
Updated: 10:17 AM EDT, Sep 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Bio-Rad Laboratories, Inc. Class A Common Stock
< Previous
1
2
3
4
5
Next >
Bio-Rad Laboratories Bets on Digital PCR, Margins and Smarter M&A Growth
↗
September 25, 2026
Bio-Rad Laboratories (NYSE:BIO) is pursuing a multi-year effort to improve growth, expand margins and strengthen free cash flow, with management emphasizing portfolio focus, operating discipline and a...
Via
MarketBeat
Bio-Rad (BIO) Q2 2026 Earnings Call Transcript
↗
August 11, 2026
Digital PCR revenue surged over 20% as clinical diagnostics grew.
Via
The Motley Fool
Topics
Earnings
Bio-Rad Laboratories Q2 Earnings Call Highlights
↗
August 05, 2026
Bio-Rad Laboratories (NYSE:BIO) reported second-quarter revenue of approximately $651 million, essentially flat from $652 million a year earlier on a reported basis and down 1.9% on a currency-neutral...
Via
MarketBeat
Topics
Earnings
Bio-Rad (NYSE:BIO) Falls After Q2 Beat as Life Science Sales Weigh
↗
August 04, 2026
Via
Chartmill
Bio-Rad Q1 2026 Revenue Misses Estimates, Outlook Cut as NYSE:BIO Faces Cautious Trading
↗
April 30, 2026
Via
Chartmill
Bio-Rad Laboratories (NYSE:BIO) Stock Plummets 12% After Q4 Earnings Miss and Weak 2026 Outlook
↗
February 12, 2026
Via
Chartmill
Topics
Earnings
Earnings Scheduled For October 29, 2025
↗
October 29, 2025
Via
Benzinga
Earnings Scheduled For July 31, 2025
↗
July 31, 2025
Via
Benzinga
Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026?
↗
June 22, 2026
Bio-Rad posts robust margins and liquidity, while Charles River leads in global drug discovery services. Explore how their fundamentals stack up for investors.
Via
The Motley Fool
Why Elliott Sees Hidden Billions Inside Bio-Rad Laboratories
↗
May 18, 2026
Elliott Management builds a stake in Bio-Rad (NYSE: BIO) to push for better performance, but family voting control could pose a hurdle.
Via
Benzinga
Bio-Rad (BIO) Q2 2025 Earnings Call Transcript
↗
May 04, 2026
Bio-Rad (BIO) Q2 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Earnings Scheduled For May 1, 2025
↗
May 01, 2025
Via
Benzinga
A Preview Of Bio-Rad Laboratories's Earnings
↗
April 30, 2025
Via
Benzinga
Earnings Scheduled For February 13, 2025
↗
February 13, 2025
Via
Benzinga
Bio-Rad (BIO) Q1 2026 Earnings Transcript
↗
May 01, 2026
Bio-Rad (BIO) Q1 2026 Earnings Transcript
Via
The Motley Fool
Topics
World Trade
Bio-Rad (BIO) Q4 2025 Earnings Call Transcript
↗
February 12, 2026
Bio-Rad (BIO) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Why a Fund Trimmed a $41 Million CompoSecure Stake Amid a 47% Stock Run
↗
December 23, 2025
Amid a monster year and, more recently, a transformative deal announcement, this move raises a sharper question about how much upside is really left at today’s valuation.
Via
The Motley Fool
Topics
Regulatory Compliance
Why a Fund Cut $4 Million of Payoneer Stock Despite Record Revenues
↗
December 23, 2025
Payoneer just posted record revenue and raised guidance, yet one fund trimmed its stake. The disconnect is where the real story is.
Via
The Motley Fool
Topics
Regulatory Compliance
Why Bio-Rad Laboratories Stock Slipped by More Than 3% on Thursday
↗
October 30, 2025
The company doesn't seem like it will generate pops in key fundamentals anytime soon.
Via
The Motley Fool
Topics
Supply Chain
Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism
October 01, 2025
Thermo Fisher Scientific Inc. (NYSE: TMO) experienced a robust surge in its stock value today, October 1, 2025, climbing an impressive 9.79% as market optimism swelled around a series of recent...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Government
Bio-Rad (BIO) Q2 EPS Jumps 51%
↗
August 01, 2025
Via
The Motley Fool
Bio-Rad Laboratories Analysts Raise Their Forecasts After Better-Than-Expected Q2 Earnings
↗
August 01, 2025
Via
Benzinga
Monolithic Power Systems, Workiva, Interface, AppFolio And Other Big Stocks Moving Higher On Friday
↗
August 01, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
July 31, 2025
Via
Benzinga
These stocks are moving in today's after hours session
↗
July 31, 2025
Discover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics.
Via
Chartmill
5 Analysts Have This To Say About Bio-Rad Laboratories
↗
June 09, 2025
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
↗
May 06, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
April 10, 2025
Via
Benzinga
Stocks Head For Weekly Gains, US Treasury Yields Fall Below 4.5%: What's Driving Markets Friday?
↗
February 14, 2025
Stocks are headed for weekly gains, with the Dow Jones dipping slightly and the S&P 500 and Nasdaq trading just above the flatline Friday.
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
January 21, 2025
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
